Substance Use and Overdose in Public Libraries: Results from a Five-State Survey in the US.


Journal

Journal of community health
ISSN: 1573-3610
Titre abrégé: J Community Health
Pays: Netherlands
ID NLM: 7600747

Informations de publication

Date de publication:
04 2022
Historique:
accepted: 03 11 2021
pubmed: 13 1 2022
medline: 27 4 2022
entrez: 12 1 2022
Statut: ppublish

Résumé

In the U.S., overdoses have become a health crisis in both public and private places. We describe the impact of the overdose crisis in public libraries across five U.S. states, and the front-line response of public library workers. We conducted a cross-sectional survey, inviting one worker to respond at each public library in five randomly selected states (CO, CT, FL, MI, and VA), querying participants regarding substance use and overdose in their communities and institutions, and their preparedness to respond. We describe substance use and overdose patterns, as well as correlates of naloxone uptake, in public libraries. Participating library staff (N = 356) reported witnessing alcohol use (45%) and injection drug use (14%) in their libraries in the previous month. Across states surveyed, 12% of respondents reported at least one on-site overdose in the prior year, ranging from a low of 10% in MI to a high of 17% in FL. There was wide variation across states in naloxone uptake at libraries, ranging from 0% of represented libraries in FL to 33% in CO. Prior on-site overdose was associated with higher odds of naloxone uptake by the library (OR 2.5, 95% CI 1.1-5.7). Although 24% of respondents had attended a training regarding substance use in the prior year, over 90% of respondents wanted to receive additional training on the topic. Public health professionals should partner with public libraries to expand and strengthen substance use outreach and overdose prevention efforts.

Identifiants

pubmed: 35020100
doi: 10.1007/s10900-021-01048-2
pii: 10.1007/s10900-021-01048-2
pmc: PMC8753323
doi:

Substances chimiques

Narcotic Antagonists 0
Naloxone 36B82AMQ7N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-350

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Drug Alcohol Depend. 2014 Dec 1;145:48-68
pubmed: 25456324
Health Soc Care Community. 2022 Jan;30(1):e175-e183
pubmed: 33988284
Int J Drug Policy. 2021 Feb;88:103038
pubmed: 33232885
Am J Health Promot. 2021 Feb;35(2):250-254
pubmed: 32662281
J Public Health (Oxf). 2007 Mar;29(1):35-9
pubmed: 17229788
Aust N Z J Public Health. 2009 Jun;33(3):280-3
pubmed: 19630850
Addiction. 2010 Apr;105(4):676-83
pubmed: 20148794
Drug Alcohol Depend. 2018 Oct 1;191:361-364
pubmed: 30195192
Int J Drug Policy. 2017 Jan;39:69-77
pubmed: 27768996
Health Promot Pract. 2018 May;19(3):361-368
pubmed: 28984482
Drug Alcohol Depend. 2011 Jan 15;113(2-3):172-6
pubmed: 20800976
Vital Health Stat 2. 2014 Apr;(166):1-73
pubmed: 24776070
Subst Abus. 2021;42(4):957-961
pubmed: 33751909
Subst Abus. 2020;41(4):468-474
pubmed: 32213045
Subst Abus. 2021;42(3):302-309
pubmed: 31852402
Health Aff (Millwood). 2016 Nov 1;35(11):2030-2036
pubmed: 27834243
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
J Addict Med. 2020 Jul/Aug;14(4):e6-e7
pubmed: 32404651
Lancet. 2011 Apr 23;377(9775):1429-37
pubmed: 21497898
CMAJ. 2004 Sep 28;171(7):731-4
pubmed: 15451834
J Urban Health. 2017 Feb;94(1):1-3
pubmed: 28070822
Int J Drug Policy. 2011 May;22(3):179-83
pubmed: 21450450
Prev Chronic Dis. 2018 May 24;15:E64
pubmed: 29806580
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174

Auteurs

Rachel Feuerstein-Simon (R)

Center for Public Health Initiatives, Perelman School of Medicine, University of Pennsylvania, 3620 Hamilton Walk, Anatomy and Chemistry Building, Room 148, Philadelphia, PA, 19104, USA. rachel.feuerstein-simon@pennmedicine.upenn.edu.

Margaret Lowenstein (M)

Department of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Roxanne Dupuis (R)

Harvard University, Cambridge, USA.

Abby Dolan (A)

Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Xochitl Luna Marti (XL)

San Francisco Department of Public Health, San Francisco, USA.

Alexandra Harvey (A)

Center for Public Health Initiatives, Perelman School of Medicine, University of Pennsylvania, 3620 Hamilton Walk, Anatomy and Chemistry Building, Room 148, Philadelphia, PA, 19104, USA.

Heba Ali (H)

Center for Public Health Initiatives, Perelman School of Medicine, University of Pennsylvania, 3620 Hamilton Walk, Anatomy and Chemistry Building, Room 148, Philadelphia, PA, 19104, USA.

Zachary F Meisel (ZF)

Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.

David T Grande (DT)

Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.

Noah Lenstra (N)

Department of Library and Information Science School of Education, The University of North Carolina at Greensboro (UNCG), Greensboro, USA.

Carolyn C Cannuscio (CC)

Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Leonard Davis Institute of Health Economics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.
Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH